These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15828113)

  • 1. Dangerous liaison: club drug use and HIV/AIDS.
    Swanson J; Cooper A
    IAPAC Mon; 2002 Dec; 8(12):330-8. PubMed ID: 15828113
    [No Abstract]   [Full Text] [Related]  

  • 2. Dangerous liaison: club drugs and HIV.
    Swanson J; Cooper A
    Posit Aware; 2003; 14(4):32-6. PubMed ID: 12951949
    [No Abstract]   [Full Text] [Related]  

  • 3. HAART, side effects, and viral transmission.
    Laurence J
    AIDS Read; 2004 May; 14(5):210-1. PubMed ID: 15198078
    [No Abstract]   [Full Text] [Related]  

  • 4. Club drugs and HIV infection: a review.
    Colfax G; Guzman R
    Clin Infect Dis; 2006 May; 42(10):1463-9. PubMed ID: 16619161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
    Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
    AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV-AIDS: answers to new questions].
    Fellay J; Cavassini M
    Rev Med Suisse; 2006 Apr; 2(60):912-7. PubMed ID: 16673722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response.
    Fardet L; Mary-Krause M; Heard I; Partisani M; Costagliola D;
    HIV Med; 2006 Nov; 7(8):520-9. PubMed ID: 17105511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sexual risk behavior among injection drug users before widespread availability of highly active antiretroviral therapy.
    Rusch ML; Farzadegan H; Tarwater PM; Safaeian M; Vlahov D; Strathdee SA
    AIDS Behav; 2005 Sep; 9(3):289-99. PubMed ID: 16133905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. As the tide turns: the changing HIV/AIDS epidemic and the criminalization of HIV exposure.
    McArthur JB
    Cornell Law Rev; 2009 Mar; 94(3):707-42. PubMed ID: 19507336
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of street drug use, HIV infection, and highly active antiretroviral therapy on reproductive hormones in middle-aged women.
    Santoro N; Arnsten JH; Buono D; Howard AA; Schoenbaum EE
    J Womens Health (Larchmt); 2005 Dec; 14(10):898-905. PubMed ID: 16372891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004.
    Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M
    Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changing face of AIDS.
    Johnston R
    AIDS Read; 2002 Sep; 12(9):373-5. PubMed ID: 12402800
    [No Abstract]   [Full Text] [Related]  

  • 13. AIDS in the Third World: how to stop the HIV infection?
    De Clercq E
    Verh K Acad Geneeskd Belg; 2007; 69(2):65-80. PubMed ID: 17550059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention. Swiss guidelines take a troubling turn.
    TreatmentUpdate; 2008 Mar; 20(2):13-8. PubMed ID: 18661650
    [No Abstract]   [Full Text] [Related]  

  • 15. Initial hospitalization and adherence to highly active antiretroviral therapy.
    Lattuada E; Lanzafame M; Gottardi M; Corsini F; Concia E; Vento S
    Clin Infect Dis; 2008 Mar; 46(6):957-8. PubMed ID: 18288910
    [No Abstract]   [Full Text] [Related]  

  • 16. Who's talking? Communication between health providers and HIV-infected adults related to herbal medicine for AIDS treatment in western Uganda.
    Langlois-Klassen D; Kipp W; Rubaale T
    Soc Sci Med; 2008 Jul; 67(1):165-76. PubMed ID: 18406030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult.
    Flanigan TP; Mitty JA
    Clin Infect Dis; 2006 Jun; 42(11):1636-8. PubMed ID: 16652322
    [No Abstract]   [Full Text] [Related]  

  • 18. HIV treatment adherence and sexual functioning.
    Miguez-Burbano MJ; Espinoza L; Lewis JE
    AIDS Behav; 2008 Jan; 12(1):78-85. PubMed ID: 17295075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression.
    Gore-Felton C; Koopman C
    Psychosom Med; 2008 Jun; 70(5):569-74. PubMed ID: 18519885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic drug monitoring and human immunodeficiency virus (HIV) antiretroviral therapy.
    Justesen US
    Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):20-31. PubMed ID: 16433887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.